Tetra Bio-Pharma Inc.

OTCPK:TBPM.Q Stock Report

Market Cap: US$515.0

Tetra Bio-Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Richard Giguere

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.6yrs
CEO ownershipn/a
Management average tenure4.7yrs
Board average tenure7.6yrs

Recent management updates

Recent updates

CEO

Richard Giguere

6.6yrs

Tenure

Mr. Richard Giguere serves as Chief Executive Officer of Tetra Natural Health Inc at Tetra Bio-Pharma Inc since October 24, 2018. He served as Executive Vice-President of Commercial Operations at Tetra Bio...

Leadership Team

NamePositionTenureCompensationOwnership
Steeve Néron
Chief Commercial Officer4.7yrsCA$313.61kno data
André Rancourt
Co-Founderno datano datano data
Leslie Auld
Chief Financial Officer3yrsno datano data
Jennifer McCaughey
Vice President of Investor Relationsno datano datano data
Dania Scott
Senior Vice President of Commercial Strategy4.7yrsno datano data
Aurelia Pauw
Senior VP of Clinical Programs & Medical Affairs4.3yrsno datano data
Richard Giguere
Chief Executive Officer of Tetra Natural Health Inc.6.6yrsno datano data
Randy Ringuette
Project Director & Member of Advisory Boardno datano datano data
Chris MacLean
Chief Operating Officer of Tetra Natural Health6yrsno datano data

4.7yrs

Average Tenure

Experienced Management: TBPM.Q's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Randy Ringuette
Project Director & Member of Advisory Board9.5yrsno datano data
Catherine Auld
Independent Director4yrsCA$56.76kno data
Steven Edgett
Member of Strategic Advisor4.8yrsno datano data
Dale Weil
Independent Director4.7yrsCA$136.76kno data
Brent Norton
Independent Chairman4.7yrsCA$151.76kno data
Adam Greenblatt
Member of Advisory Board9.5yrsno datano data
Erin Prosk
Member of Advisory Board9.5yrsno datano data
Charles Campbell
Member of Advisory Board9.5yrsno datano data
Louis-Philippe de Lorimier
Member of Clinical Advisory Board7.7yrsno datano data
Cheryl Cullen
Member of Clinical Advisory Board7.6yrsno datano data
Aubrey Webb
Member of Clinical Advisory Board7.6yrsno datano data
John Kim
Independent Director4yrsCA$56.76kno data

7.6yrs

Average Tenure

Experienced Board: TBPM.Q's board of directors are considered experienced (7.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 16:55
End of Day Share Price 2025/05/09 00:00
Earnings2022/08/31
Annual Earnings2021/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tetra Bio-Pharma Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rahul SarugaserParadigm Capital, Inc.